Biodimension

Executive Summary

Biodimension is an Indian biotechnology company leveraging a full-stack bioprinting platform to develop biofabricated human tissues and organoids. Founded in 2020 and headquartered in Vellore, the company integrates design, cells, and biomaterials to create functional tissue replicas for drug screening and safety testing. By providing human-relevant alternatives to animal models, Biodimension addresses a critical need in the pharmaceutical, cosmetic, and chemical industries, aligning with global regulatory trends favoring non-animal testing methods. The company has raised $22 million to date and operates as a platform-stage private entity, positioned to capture a growing market for advanced in vitro models.

Upcoming Catalysts (preview)

• Q3 2026Securing a major pharmaceutical partnership for drug screening services60% success
• Q4 2026Closing a Series B funding round of $30–50 million70% success
• Q1 2027Launch of the first commercial organoid product for toxicity testing50% success